Ionis Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $226,576 | $134,000 | $225,250 | $119,497 |
Gross Profit | 222,746 | 132,929 | 215,507 | 111,695 |
EBITDA | -125,000 | -37,835 | -114,967 | |
EBIT | -148,656 | -43,414 | -120,618 | |
Net Income | -104,349 | -140,480 | -66,265 | -142,803 |
Net Change In Cash | 226,576 | 134,000 | 225,250 | 119,497 |
Free Cash Flow | -144,183 | -111,296 | -140,141 | -155,668 |
Cash | 242,077 | 334,605 | 293,993 | 348,889 |
Basic Shares | 157,908 | 148,593 | 145,958 | 145,538 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $705,138 | $787,647 | $587,000 | $810,000 |
Gross Profit | 693,923 | 778,514 | 573,000 | 799,000 |
EBITDA | -475,081 | -230,010 | -227,758 | -239 |
EBIT | -252,508 | -249,863 | -19,799 | |
Net Income | -453,897 | -366,286 | -270,000 | -29,000 |
Net Change In Cash | 705,138 | 787,647 | 587,000 | 810,000 |
Cost of Revenue | -592,301 | 471,527 | ||
Free Cash Flow | -546,227 | -335,524 | -294,469 | 12,898 |
Cash | 242,077 | 399,266 | 1,987,000 | 2,115,000 |
Basic Shares | 149,514 | 143,190 | 141,848 | 141,021 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.43 |
2024-09-30 | -$0.95 |
2024-06-30 | -$0.45 |
2024-03-31 | -$0.98 |
